Veterinary Reference Laboratory Market worth $6.46 billion by 2030
The report "Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030", is projected to grow from USD 4.75 billion in 2025 to USD 6.46 billion by 2030, at a CAGR of 6.3%.
Browse 450 market data Tables and 60 Figures spread through 450 Pages and in-depth TOC on "Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/veterinary-reference-laboratory-market-256972714.html
Growth in this market is largely driven by the increasing incidence of zoonotic and chronic animal diseases, rising pet ownership, and the growing emphasis on preventive animal healthcare. The demand for advanced diagnostic services, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has led to the rapid establishment of high-capacity reference laboratories across both developed and emerging regions. Furthermore, technological progress in automation, AI-driven image analysis, and molecular testing is enhancing diagnostic speed and accuracy, strengthening veterinarians’ confidence and pet owners’ reliance on lab-based diagnostics. Additionally, the integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is enhancing operational efficiency by improving sample tracking, reducing turnaround times, and facilitating remote result accessibility. The increasing focus on early disease detection, preventive wellness programs, and the corporatization of veterinary practices has further boosted the inflow of diagnostic samples to reference labs. The market continues to face certain restraints, including high testing and operational costs, a shortage of skilled professionals, and stringent regulatory frameworks governing veterinary diagnostics. Ensuring quality control across global operations, maintaining biosecurity standards, and managing sample logistics remain critical challenges for laboratories seeking to maintain consistency, accuracy, and sustainable growth.
By service, the molecular diagnostics segment accounted for the largest market share in 2024.
The service types in the veterinary reference laboratory market are clinical chemistry, hematology, immunodiagnostics, molecular diagnostics, urinalysis, histopathology, cytology, and microbiology. Within this portfolio, the molecular diagnostics segment is projected to record the highest CAGR during the forecast period. This rapid growth is driven by the rising adoption of PCR, qPCR, RT-PCR, and next-generation sequencing (NGS) for early and accurate detection of infectious agents, genetic disorders, and emerging zoonotic threats. The increasing demand for high-sensitivity testing, advancements in assay automation, and the integration of AI-supported molecular analysis are further accelerating the adoption of molecular diagnostic services across veterinary hospitals, clinics, and research institutions. Additionally, growing awareness of preventive health screening and the need for definitive diagnostics in complex cases continue to position molecular diagnostics as the fastest-advancing segment in the market.
By animal type, the companion animals segment led the market in 2024.
By animal type, the veterinary reference laboratory market is segmented into companion animals and livestock animals. Companion animals accounted for the largest market share in 2024. The dominance of this segment is driven by the rising global pet population, increased spending on pet health, and the growing adoption of advanced diagnostic testing in small animal practices. Higher incidence of chronic diseases, greater awareness of preventive care, and the expanding availability of specialized diagnostic panels for dogs and cats further support segment growth. Additionally, the rapid integration of molecular diagnostics, digital pathology, and AI-enabled diagnostic tools in companion animal care is accelerating demand, making it the fastest-expanding segment throughout the forecast period. Within the companion animal segment, dogs accounted for the largest market share.
By End User, the point-of-care/ in-house labs segment is expected to register the highest CAGR during the forecast period.
Between 2025 and 2030, point-of-care (POC)/ in-house labs are expected to be the fastest-growing end-use segment. Veterinary practices are increasingly adopting compact, easy-to-use analyzers for routine tests such as chemistry, hematology, and infectious disease screening. The key drivers are the need for faster results, quicker clinical decision-making, and reduced dependency on external labs for time-sensitive tests. Smaller practices also prefer POC solutions because they improve efficiency, enhance client satisfaction, and help reduce overall turnaround time. As costs of POC analyzers continue to decrease and technology becomes more user-friendly, adoption is expected to grow rapidly across both small and mid-sized veterinary clinics.
North America dominated the market in 2024.
Regionally, the veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2024, accounting for 43.3% of the global revenue. This leadership is primarily driven by the high adoption of advanced diagnostic technologies, the strong presence of leading veterinary reference lab providers (such as IDEXX Laboratories, Zoetis, and Mars Veterinary Health), and a well-established veterinary healthcare infrastructure. The region’s growing focus on preventive animal care and increasing expenditure on pet health services have further strengthened its market position. Within North America, the US held the largest share due to a high companion animal population, increasing prevalence of zoonotic diseases, and the widespread availability of specialized diagnostic services. The country also benefits from a strong network of veterinary hospitals and partnerships between clinics and reference laboratories, ensuring consistent test volumes and rapid turnaround times. Meanwhile, Canada is experiencing steady growth, supported by rising pet adoption, expanding veterinary service capacity, and increasing government and private investments in veterinary diagnostics and digital laboratory infrastructure.
The prominent players in the veterinary software market are IDEXX Laboratories, Inc. (US), Mars, Incorporated (US), Zoetis services LLC(US), GD (Netherlands), Laboklin GmbH & Co KG (Germany), CVS Limited (UK), National Veterinary Services Laboratory USDA- APHIS (US), Animal and Plant Health Agency (UK), ICAR–NIVEDI (India), National Veterinary Services (UK), Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL) (US), Animal Health Diagnostic Center, Cornell University (US), Colorado State University (Veterinary Diagnostic Laboratory) (US), Biobest Laboratories ltd (UK), Private Veterinary Clinic San Marco Srl Unipersonale (Italy), Royal Veterinary college, University of London (UK), University of Guelph, Animal Health Laboratory (Canada), Vaxxinova (Germany), Mira Vista Labs (US), Ellie Diagnostics (Germany), Protatek International, Inc. (US), The Pirbright Institute (UK), CVR Laboratory (CVRL) (UAE), Veterinary Pathology Group (UK), , and Friedrich-Loeffler-Institut (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Veterinary Reference Laboratory Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
